CorMedix Inc. — Director's Dealing 2012

Sep 28, 2012

SEC Form 4/A — Form 4/A

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2012-09-20

Reporting Person: Duffy Matthew (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Senior Convertible Note (convertible into common stock)	$		n/a ()	0	Direct
Warrant (right to purchase common stock)	$		n/a ()	0	Direct

Footnotes

F1: On September 24, 2012, the reporting person mistakenly reported on a Form 4 (the "Form 4") the purchase of $10,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's common stock at a conversion price of $0.35 per share; and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share. The reporting person deposited $10,000 in escrow for such purchase, which will remain in escrow until the final closing, if any, as determined by the Company.